Search results
Is Moderna Inc (NASDAQ: MRNA) Stock On Course For Another Boom Or Bust? – Marketing Sentinel
Marketing Sentinel· 3 days agoDuring the last session, Moderna Inc (NASDAQ:MRNA)’s traded shares were 4.04 million, with the beta value of the company hitting 1.70. At the end of the trading day, the stock ...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 1 day agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 3 days agoModerna’s respiratory syncytial virus (RSV) vaccine mRESVIA has received US Food and Drug...
FDA approves Moderna's mRNA RSV vaccine for older adults
News Channel Nebraska· 5 days agoBy Jen Christensen, CNN
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 6 days agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest...
FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program - Moderna...
Benzinga· 3 days agoThursday, the FDA selected Moderna Inc’s MRNA mRNA-3705 for the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) pilot program. “Selection for this ...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 6 days agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 4 days agoOn Friday, Pfizer Inc (NYSE: PFE) revealed its drug for an advanced form of lung cancer showed...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA TODAY via Yahoo News· 3 hours agoDuring the Vaccines and Related Biological Products Advisory Committee, health experts from vaccine manufacturers Pfizer, Moderna and Novavax each told the panel they were ...
FDA approves Moderna's RSV shot for older adults
Becker’s Hospital Review· 6 days agoThe FDA has given the green light to Moderna's mRNA-based respiratory syncytial virus vaccine, specifically for older adults, the drugmaker announced May 31. "This approval ...